CONVENIA®

Composition:

• Cefovecin Sodium 800 mg
  

Indications:

Dogs- Treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G).

Cats- Treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.

Dosing & Administration:

Aseptically reconstitute CONVENIA^® with 10 mL sterile water for injection. Shake and allow vial to sit until all material is visually dissolved. The resulting solution contains cefovecin sodium equivalent to 80 mg/mL cefovecin.

• 8mg/kg (0.1 mL/kg) body weight subcutaneously in dogs and cats above 4 months of age.

• A second subcutaneous injection of CONVENIA^® may be administered in dogs if response to therapy is not complete.
  

The decision for a second injection for any individual dog should take into consideration such factors as progress toward clinical resolution, the susceptibility of the causative organisms, and the integrity of the dog’s host-defense mechanisms.

 

Important safety information:

CONVENIA^® is contraindicated in dogs and cats with known allergy to cefovecin or to β-lactam (penicillins and cephalosporins) group antimicrobials. The safe use of CONVENIA^® in dogs or cats less than 4 months of age (see Animal Safety) and in breeding or lactating animals has not been determined. Safety has not been established for IM or IV administration. The long-term effects on injection sites have not been determined.

Packaging:

• 10 ml multiuse vial containing 800 mg of Cefovecin sodium as lyophilized cake.